Cost-Effectiveness of Apatinib and Cabozantinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer

Background: The effectiveness of apatinib and cabozantinib for the treatment of radioactive iodine-refractory differentiated thyroid cancer (RAIR-DTC) has been demonstrated recently. We aimed to evaluate the cost-effectiveness of these treatments from the Chinese healthcare system perspective.Method...

Full description

Saved in:
Bibliographic Details
Main Authors: Bo Shi (Author), Wenbiao Ma (Author), Hongshuai Pan (Author), Yang Shi (Author), Huan Zhang (Author), Shenghai Xing (Author)
Format: Book
Published: Frontiers Media S.A., 2022-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available